G0103
No office ratePsa screening
G0103 is for screening PSA testing; G0102 is for the screening digital rectal examination.
On this page
CMS RVU26D · Effective 2026-10-01
G0102 Prostate screening Medicare reimbursement rates in Ohio
Report G0102 for a prostate cancer screening digital rectal examination, in which a clinician palpates the prostate through the rectum. Compare G0102 office and facility rates across CMS payment localities in Ohio.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for G0102 in Ohio?
Ohio has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$22.82
1 of 1 localities have a supported rate.
Payment area: Ohio
One mapped payment locality.
Facility setting
$7.57
1 of 1 localities have a supported rate.
Payment area: Ohio
One mapped payment locality.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Cancer screening
About G0102: Prostate cancer screening digital examination
Report G0102 for a prostate cancer screening digital rectal examination, in which a clinician palpates the prostate through the rectum.
G0102 represents a screening examination in which a clinician inserts a gloved, lubricated finger into the rectum to assess the prostate by palpation. Primary care clinicians and urologists commonly perform it during an outpatient visit. The exam can assess features such as prostate size, contour, and palpable irregularities; the code identifies the screening service, not a laboratory test or evaluation of urinary symptoms.
Select G0102 when the documented purpose is prostate cancer screening and the digital examination was performed. The note should establish screening intent and record the examination and relevant findings. Do not use this code for a PSA blood test; G0103 identifies screening PSA testing. CMS physician fee schedule values for G0102 include work and practice expense, with practice expense values that differ by setting.
Where the value comes from
- Work RVU0.18 · 25%
- Practice expense (office) RVU0.54 · 74%
- Malpractice RVU0.01 · 1%
7.3K
Medicare services in 2024 · #1635 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
G0102 compared with similar codes
Office rates for Ohio, from the same CMS release.
84153
No office rateAssay of psa total
Use 84153 for PSA testing in a diagnostic context; G0103 identifies screening PSA testing, while G0102 identifies the screening examination.
$90.97
99213 represents an office E/M service, not the prostate screening examination itself. G0102 identifies the digital screening examination.
Compare G0102 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Ohio →
Office / nonfacility
$22.82
Facility
$7.57
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for G0102 in Ohio.
PPRRVU2026_Oct_nonQPP.csv
15,084
- Code
- G0102
- Physician work
- 0.18
- Practice expense
- 0.54
- Malpractice
- 0.01
GPCI2026.csv
85
- Locality
- Ohio
- Physician work
- 1.000
- Practice expense
- 0.913
- Malpractice
- 1.008
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.18 | × 1.000 | 0.1800 |
| Practice expense | 0.54 | × 0.913 | 0.4930 |
| Malpractice | 0.01 | × 1.008 | 0.0101 |
| Total RVUs | 0.6831 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Ohio$22.82
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0.18 | 1 |
| Practice expense | 0.54 | 0.913 |
| Malpractice | 0.01 | 1.008 |
(0.18 × 1 + 0.54 × 0.913 + 0.01 × 1.008) × $33.4009 = $22.82
Facility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0.18 | 1 |
| Practice expense | 0.04 | 0.913 |
| Malpractice | 0.01 | 1.008 |
(0.18 × 1 + 0.04 × 0.913 + 0.01 × 1.008) × $33.4009 = $7.57
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
G0102 billing questions
When should G0102 be used instead of G0103?
G0102 identifies the digital rectal examination; G0103 identifies a screening prostate-specific antigen blood test. Report the service actually performed and documented.
Does G0102 include the PSA blood test?
No. G0102 is for the screening digital examination, not blood collection or PSA analysis.
What documentation supports G0102?
Document that the examination was performed for screening, describe the digital prostate examination, and record relevant findings.
Can G0102 be reported with G0103?
The codes identify different screening services: a digital examination and a PSA test. Report both only when both services were performed and documented.
Is G0102 selected by examination time or number of areas examined?
No time or area-count level is identified for this code. It represents the screening digital examination of the prostate.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
15,081G0089,,Adm subq drug 1st home visit,X,,0.00,0.00,,0.00,,0.00,0.00,0.00,9,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
15,082G0090,,Adm iv chemo 1st home visit,X,,0.00,0.00,,0.00,,0.00,0.00,0.00,9,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
15,083G0101,,Ca screen;pelvic/breast exam,A,,0.44,0.68,,0.23,,0.07,1.19,0.74,0,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
15,084G0102,,Prostate ca screening; dre,A,,0.18,0.54,,0.04,,0.01,0.73,0.23,0,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
15,085G0103,,Psa screening,X,,0.00,0.00,,0.00,,0.00,0.00,0.00,9,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
15,086G0104,,Ca screen;flexi sigmoidscope,A,,0.82,5.50,,0.67,,0.11,6.43,1.60,0,000,0.00,0.00,0.00,2,0,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
15,087G0105,,Colorectal scrn; hi risk ind,A,,3.18,7.73,,1.34,,0.41,11.32,4.93,0,000,0.00,0.00,0.00,2,0,1,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
8213282,NY,99,REST OF NEW YORK,1.000,0.950,0.703
8311502,NC,00,NORTH CAROLINA,1.000,0.933,0.639
8403302,ND,01,NORTH DAKOTA**,1.000,1.000,0.406
8515202,OH,00,OHIO,1.000,0.913,1.008
8604312,OK,00,OKLAHOMA,1.000,0.893,0.777
8702302,OR,01,PORTLAND,1.016,1.111,0.744
8802302,OR,99,REST OF OREGON,1.000,0.996,0.703